The transient receptor potential vanilloid 1 is associated with active inflammation in ulcerative colitis

14Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The transient receptor potential vanilloid 1 (TRPV1) may play a role in the pathogenesis of ulcerative colitis (UC). The aim of the study was to determine the gene and protein expression of TRPV1 in UC patients and noninflamed controls. Gene expression was performed by RT-PCR, and protein expression was performed by immunohistochemistry. The gene expression of TRPV1 was significantly increased in the remission UC group compared to active UC patients (P = 0 002), and an upregulation of the TRPV1 gene was associated with clinical outcomes such as age at diagnosis (<40 years) (P = 0 02) and clinical disease course characterized by relapsing and continuous activity (P = 0 07). TRPV1 immunoreactive cells were conspicuously higher in all intestinal layers from active UC patients compared with noninflamed control tissue. These findings suggest that TRPV1 might be involved in UC pathogenesis.

Cite

CITATION STYLE

APA

Toledo-Mauriño, J. J., Furuzawa-Carballeda, J., Villeda-Ramírez, M. A., Fonseca-Camarillo, G., Meza-Guillen, D., Barreto-Zúñiga, R., & Yamamoto-Furusho, J. K. (2018). The transient receptor potential vanilloid 1 is associated with active inflammation in ulcerative colitis. Mediators of Inflammation, 2018. https://doi.org/10.1155/2018/6570371

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free